Non-vaccine nasal spray could protect against COVID-19
pharmaphorum
SEPTEMBER 10, 2020
That could be important if it takes longer than expected to bring vaccines and antibodies to market, said a spokesman for the companies, pointing to the news this week that AstraZeneca has halted phase 3 trials of its COVID-19 vaccine candidate AZD1222 after a serious adverse reaction in one patient.
Let's personalize your content